A predictive model involving serum uric acid, C-reactive protein, diabetes, hypercholesteremia, multiple lesions for restenosis risk in everolimus-eluting stent-treated coronary heart disease patients
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.